Targeting Bone Marrow-Derived Fibroblasts for Renal Fibrosis
- PMID: 31399971
- DOI: 10.1007/978-981-13-8871-2_14
Targeting Bone Marrow-Derived Fibroblasts for Renal Fibrosis
Abstract
Renal fibrosis is a major pathological feature of chronic kidney disease, which is characterized by massive fibroblast activation and excessive production and deposition of extracellular matrix (ECM). Renal fibrosis results in progressive loss of kidney function; however, there is currently no effective therapy available clinically to treat or even reverse renal fibrosis. Although activated fibroblasts/myofibroblasts are responsible for the production and deposition of ECM, their origin has been debatable. Recent studies have provided compelling evidence that bone marrow-derived fibroblast precursors contribute significantly to the population of myofibroblasts and the development of renal fibrosis. Therefore, targeting the molecular signaling mechanisms underlying the recruitment and activation of the bone marrow-derived fibroblast precursors may serve as novel therapeutic strategy for chronic kidney disease. In this review, we appraise recent advances in our understanding of the recruitment and activation of bone marrow-derived fibroblast precursors in the kidney and the development of renal fibrosis and highlight novel molecular signaling pathways that may lead to the development of new therapies for chronic kidney disease.
Keywords: Bone marrow-derived fibroblast precursors; Chemokine; Chronic kidney disease; Cytokine; Extracellular matrix; Fibroblasts; Monocyte-to-fibroblast transition; Renal fibrosis.
Similar articles
-
Role of Bone Marrow-Derived Fibroblasts in Renal Fibrosis.Front Physiol. 2016 Feb 25;7:61. doi: 10.3389/fphys.2016.00061. eCollection 2016. Front Physiol. 2016. PMID: 26941655 Free PMC article. Review.
-
JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.J Am Soc Nephrol. 2015 Dec;26(12):3060-71. doi: 10.1681/ASN.2014070717. Epub 2015 Jun 1. J Am Soc Nephrol. 2015. PMID: 26032813 Free PMC article.
-
The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis.Kidney Int. 2017 Dec;92(6):1433-1443. doi: 10.1016/j.kint.2017.04.021. Epub 2017 Jul 21. Kidney Int. 2017. PMID: 28739140 Free PMC article.
-
The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis.Kidney Int. 2014 Aug;86(2):327-37. doi: 10.1038/ki.2014.64. Epub 2014 Mar 19. Kidney Int. 2014. PMID: 24646857 Free PMC article.
-
The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis.Differentiation. 2016 Sep;92(3):102-107. doi: 10.1016/j.diff.2016.05.008. Epub 2016 Jun 1. Differentiation. 2016. PMID: 27262400 Review.
Cited by
-
Impaired ATG16L-Dependent Autophagy Promotes Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction Through Inducing EndMT by NF-κB Signal Pathway.Front Immunol. 2021 Apr 13;12:650424. doi: 10.3389/fimmu.2021.650424. eCollection 2021. Front Immunol. 2021. PMID: 33927720 Free PMC article.
-
Crosstalk between proximal tubular epithelial cells and other interstitial cells in tubulointerstitial fibrosis after renal injury.Front Endocrinol (Lausanne). 2024 Jan 8;14:1256375. doi: 10.3389/fendo.2023.1256375. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260142 Free PMC article. Review.
-
Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epithelial-to-Mesenchymal Transition Not Only via Inducing Autophagy but Also via Stabilizing IκB-α.Front Immunol. 2022 Jan 24;12:753412. doi: 10.3389/fimmu.2021.753412. eCollection 2021. Front Immunol. 2022. PMID: 35140705 Free PMC article.
-
STAT6 Deficiency Attenuates Myeloid Fibroblast Activation and Macrophage Polarization in Experimental Folic Acid Nephropathy.Cells. 2021 Nov 6;10(11):3057. doi: 10.3390/cells10113057. Cells. 2021. PMID: 34831280 Free PMC article.
-
Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis.Front Immunol. 2021 Aug 26;12:735014. doi: 10.3389/fimmu.2021.735014. eCollection 2021. Front Immunol. 2021. PMID: 34512669 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources